ImageneBio, Inc.
IMA
$5.84
-$0.03-0.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -142.34% | -145.39% | -24.01% | -- | -- |
| Total Depreciation and Amortization | 200.74% | 26.77% | -32.31% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 885.27% | 1,028.64% | 2.76% | -- | -- |
| Change in Net Operating Assets | -216.49% | -1,553.77% | -1,165.70% | -- | -- |
| Cash from Operations | -107.75% | -185.87% | -124.42% | -- | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -105.90% | -- | -- |
| Cash from Investing | -779.01% | -743.42% | -152.27% | -- | -- |
| Total Debt Issued | -100.00% | 100.00% | 100.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 158,044.44% | 158,044.44% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3,031.14% | 7,621.57% | 8,398.48% | -- | -- |
| Cash from Financing | 637.98% | 1,806.78% | 1,861.60% | -- | -- |
| Foreign Exchange rate Adjustments | 741.10% | 12,120.00% | 594.25% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,153.65% | 719.38% | 2,673.03% | -- | -- |